Quick Answer
Pharma-Bio Serv, Inc. reported Total Revenue of $9.00 million for fiscal year 2025.
Pharma-Bio Serv, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $9.00M | -5.3% |
| 2024 | $9.51M | -44.0% |
| 2023 | $16.98M | -12.5% |
| 2022 | $19.40M | -3.6% |
| 2021 | $20.12M | -6.7% |
| 2020 | $21.56M | +10.5% |
| 2019 | $19.51M | +9.6% |
| 2018 | $17.80M | +33.8% |
| 2017 | $13.30M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $2.29M | -7.1% | +16.9% |
| July 31, 2025 | $1.96M | -18.8% | -18.8% |
| April 30, 2025 | $2.42M | +1.7% | -2.2% |
| January 31, 2025 | $2.47M | +3.8% | +2.2% |
| July 31, 2024 | $2.42M | -47.2% | +1.7% |
| April 30, 2024 | $2.38M | -47.9% | -0.1% |
| January 31, 2024 | $2.38M | -43.8% | -48.0% |
| July 31, 2023 | $4.58M | -4.1% | +0.3% |
- Pharma-Bio Serv, Inc. showed a decrease of -5.3% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Pharma-Bio Serv, Inc.’s total revenue has declined by 32.3% (from $13.30 million to $9.00 million).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: